News >
21/03/2006 - 21:00

Phylogica Ltd - 16/03/2006

By Staff Reporters
21/03/2006 - 21:00
Share to

Bookmark

Save articles for future reference.
Subscribe to BN Log In

Has announced its first commercial partnering agreement with international biotechnology company Opsona Therapeutics to develop a new class of Phylomer® drugs targeting inflammatory diseases

X

To read our articles you will need to either login or subscribe.